Tormere Analytics
>/
OverviewMarket NewsStock ResearchChartsPortfolio LabOptions LabCalculatorsWatchlist
Data Explorer
Articles
Pricing
Privacy PolicyTerms of Service

Stephen J. Hill

Chief Operating Officer

SEC EDGAR ↗

Chief Operating Officer at Lyell Immunopharma, Inc., filing insider transactions between 2026-02-10 and 2026-05-11.

Total Purchases
—
0 transactions
Total Sales
$33K
3 transactions
Companies Traded
1
3 total filings
Active Since
2026-02-10
Last: 2026-05-11

Companies

LYEL2026-05-11

Lyell Immunopharma, Inc.

↓ $33K (3)

Other Reporting Insiders at Lyell Immunopharma, Inc.

  • ARCH Venture Fund XIII, L.P.
    10% Owner
    Last filing 2026-11-04
  • ARCH Venture Partners IX, LLC
    10% Owner
    Last filing 2026-11-04
  • Jarrad Mattieu Aguirre
    Chief Medical Officer
    Last filing 2026-10-12
  • David Shook
    Chief Medical Officer
    Last filing 2026-09-10
  • Gary K. Lee
    Chief Scientific Officer
    Last filing 2026-08-21
  • Stephen J. Hill
    Chief Operating Officer
    Last filing 2026-08-21
  • Lynn Seely
    Director & President and CEO
    Last filing 2026-08-21

Transaction History

DateTickerTypeSharesPriceValueOwned After
2026-05-11LYELSale89$18.92$2K17.9KSEC ↗
2026-02-11LYELSale1,236$23.39$29K17.8KSEC ↗
2026-02-10LYELSale109$23.12$3K19.0K
Veronica Sanchez Bulis
VP, Corporate Controller
Last filing 2026-08-10
SEC ↗